Theresa Burkard

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Disease Activity

Roux En Y Gastric Bypass

Top Venues

Pharmacoepidemiology and drug safety

Rheumatology advances in practice

This page only lists publications with an associated author ORCID identifier.

Publications

Theresa Burkard, Kim López-Güell, Artem Gorbachev, Lucía Bellas, Annika M Jödicke, Edward Burn, Maria de Ridder, Mees Mosseveld, Jasmine Gratton, Sarah Seager, Dina Vojinovic, Miguel Angel Mayer, Juan Manuel Ramírez-Anguita, Angela Leis Machín, Marek Oja, Raivo Kolde, Klaus Bonadt, Daniel Prieto Alhambra, Chistian Reich, Martí Català
Calculating daily dose in the Observational Medical Outcomes Partnership Common Data Model. Pharmacoepidemiology and drug safety 33 (6) (2024)
Maria Luisa Faquetti, Adrian Martinez-De la Torre, Theresa Burkard, Guillaume Obozinski, Andrea Michelle Burden
Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining. Pharmacoepidemiology and drug safety 32 (3) (2023)
Theresa Burkard, Enriqueta Vallejo-Yagüe, Kim Lauper, Axel Finckh, Thomas Hügle, Andrea M Burden
Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab. RMD open 9 (4) (2023)
Maria Kalweit, Andrea Michelle Burden, Joschka Boedecker, Thomas Hügle, Theresa Burkard
Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs. PLoS computational biology 19 (6) (2023)
Maria Luisa Faquetti, Adrian Martinez-De la Torre, Theresa Burkard, Guillaume Obozinski, Andrea Michelle Burden
Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining. Pharmacoepidemiology and drug safety 32 (3) (2023)
Maria Luisa Faquetti, Adrian Martinez-De la Torre, Theresa Burkard, Guillaume Obozinski, Andrea Michelle Burden
Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining. Pharmacoepidemiology and drug safety 32 (3) (2023)
Enriqueta Vallejo-Yagüe, Theresa Burkard, Raphael Micheroli, Andrea Michelle Burden
Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort. BMJ open 12 (9) (2022)
Theresa Burkard, Enriqueta Vallejo-Yagüe, Thomas Hügle, Axel Finckh, Andrea Michelle Burden
Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland. BMJ open 12 (3) (2022)
Maria Luisa Faquetti, Adrian Martinez-De la Torre, Theresa Burkard, Guillaume Obozinski, Andrea Michelle Burden
Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining. Pharmacoepidemiology and drug safety (2022)
Theresa Burkard, Ross D Williams, Enriqueta Vallejo-Yagüe, Thomas Hügle, Axel Finckh, Diego Kyburz, Andrea Michelle Burden
Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients. Rheumatology advances in practice 5 (3) (2021)